We serve Chemical Name:potassium 4-(hydroxymethyl)phenyltrifluoroborate CAS:1015082-78-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:potassium 4-(hydroxymethyl)phenyltrifluoroborate
CAS.NO:1015082-78-6
Synonyms:amtb228;m-2044
Molecular Formula:C7H7BF3KO
Molecular Weight:214.03400
HS Code:
Physical and Chemical Properties:
Melting point:210-215 °C
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:20.23000
Exact Mass:214.01800
LogP:1.23330
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like amtb228 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,m-2044 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,m-2044 Use and application,m-2044 technical grade,usp/ep/jp grade.
Related News: Prime Minister Scott Morrison said Saturday that all travelers from mainland China allowed into Australia had to be quarantined for 14 days. potassium 4-(hydroxymethyl)phenyltrifluoroborate manufacturer In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn. potassium 4-(hydroxymethyl)phenyltrifluoroborate supplier In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn. potassium 4-(hydroxymethyl)phenyltrifluoroborate vendor In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn. potassium 4-(hydroxymethyl)phenyltrifluoroborate factory AstraZeneca Plc said on Monday that its cancer drug met the main goal of delaying the progression of a form of lung cancer.
